Last reviewed · How we verify
NCT04377581
COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior
trial in Public Health in 18,251 participants. Completed in 10 July 2020.
10 July 2020
Quick facts
| Lead sponsor | Milton S. Hershey Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 18,251 |
| Start date | 9 April 2020 |
| Primary completion | 10 July 2020 |
| Estimated completion | 10 July 2020 |
| Sites | 1 location across United States |
Conditions studied
- Public Health — all drugs for Public Health →
- Demography — all drugs for Demography →
- Pandemics — all drugs for Pandemics →
- Corona Virus Infection — all drugs for Corona Virus Infection →
Sponsor
Milton S. Hershey Medical Center
Who can join
18 and older, any sex, with Public Health or Demography. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Participants are invited to include detailed free-text answers to make sure their COVID-19 experiences are heard.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
COVID 19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues.
Mohapatra S, Ayash Kumar P, Farooq U, Jain P, et al · · 2022 · cited 3× · PMID 35645588 · DOI 10.1016/j.jsps.2022.05.004
Verify or expand the search:
- PubMed search for NCT04377581
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Public Health
Currently open trials in the same condition.
- NCT06891495 — Evaluating an AI-Generated Health Podcast · recruiting
- NCT06924580 — Early ECG Prediction of Multi-system Disease Cohort Establishment and Follow Up · recruiting
Other Milton S. Hershey Medical Center trials
Trials by the same sponsor.
- NCT05180552 — The HEALiX: Comparing the Efficacy of the HEALiX Device With Wrist Restraints in a Critical Care Setting · NA · withdrawn
- NCT07461844 — Transdiagnostic Sleep and Circadian Treatment for Autistic Adults · NA · not yet recruiting
- NCT06253858 — Ultrasound (US) Guided External Ventricular Catheter Placement · NA · not yet recruiting
- NCT07225699 — IN PATIENTS WITH CORNEAL ABRASIONS TREATED WITH COLLAGEN CORNEAL SHIELDS IN THE EMERGENCY DEPARTMENT SETTING · NA · not yet recruiting
- NCT07461168 — Penn State Emergency Medicine CarES: Care-partner Evaluation and Sourcing in the Emergency Department · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04377581 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Milton S. Hershey Medical Center
- Last refreshed: 16 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04377581.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing